Skip to Content
-
PR information
Notice Regarding the Conclusion of a Basic Agreement Pertaining to the Commercialization of Next-Generation Veterinary Healthcare Platform Between 12 Pharmacy Inc., animo Co., Ltd., and Alfresa Corporation
-
PR information
Notice Regarding a Verification Test on Improving Dietary Habits Through PHR-Data-Utilizing Product Proposals and Health Support Services Aimed at Extending Healthy Life Expectancies and Preventing Lifestyle-Related Diseases in Tsukuba City
-
PR information
Notice Regarding the Capital and Business Alliances Between Alfresa Corporation and Ember LifeSciences, Inc. Aimed at Improving Pharmaceutical Cold Chain Transportation Quality
-
PR information
Notice of the Conclusion of a Basic Agreement on Alfresa Corporation's Assumption of Assets Related to SEGA SAMMY BASEBALL and Preparations for the Establishment of a New Adult Amateur Baseball Club
-
PR information
Notice Regarding the Capital and Business Alliance Between Alfresa Corporation and eMind, Inc. Aimed at Helping Improve the Quality of Healthcare and Patients' Quality of Life
-
PR information
Notice Regarding the Joint Establishment of a Working Group Focused on the Clinical Diagnostic Reagents Wholesaling Business by Alfresa Corporation and Seiko CO., LTD
-
PR information
Notice Regarding Achievement of ISO 9001 Certification by Subsidiaries: Efforts to Improve Logistics Quality in the Alfresa Group
-
PR information
Notice Regarding Alliance Between Alfresa Corporation and Choraku Choju K.K. to Eliminate Social Isolation and Extend Healthy Life Expectancies
-
PR information
Notice Regarding an Alliance Between Alfresa Corporation and BELLSYSTEM24, Inc. to Offer D-REACH, an Outsourcing-Based Information Provision Activity Support Service for Pharmaceutical Manufacturers
-
PR information
Notice Regarding Alliance Between Alfresa Corporation, CMIC HOLDINGS Co., Ltd., and CMIC Trust Co., Ltd. for the Establishment of Comprehensive Vaccination Support Platforms
